e-learning
resources
London 2016
Sunday, 04.09.2016
Molecular targets in pulmonary disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Level of soluble molecules of major histocompatibility complex CLASS II in serum, sputum and exhaled breath condensate in COPD of patients with an exacerbation of COPD
Igor A. Klimanov (Moscow, Russian Federation), Igor A. Klimanov, Svetlana Soodaeva, Timur Li, Nailya Kubysheva, Larisa Postnikova, Viktor Novikov, Lidiya Nikitina
Source:
International Congress 2016 – Molecular targets in pulmonary disease
Session:
Molecular targets in pulmonary disease
Session type:
Thematic Poster
Number:
885
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Igor A. Klimanov (Moscow, Russian Federation), Igor A. Klimanov, Svetlana Soodaeva, Timur Li, Nailya Kubysheva, Larisa Postnikova, Viktor Novikov, Lidiya Nikitina. Level of soluble molecules of major histocompatibility complex CLASS II in serum, sputum and exhaled breath condensate in COPD of patients with an exacerbation of COPD. Eur Respir J 2016; 48: Suppl. 60, 885
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients
Source: Eur Respir J, 58 (2) 2003024; 10.1183/13993003.03024-2020
Year: 2021
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016
Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts)
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues)
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011
Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Influence of inflammatory phenotype in severe refractory asthma on metabolomic profile of oxidative stress in exhaled breath condensate (EBC)
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Hydrogen sulfide (H
2
S) in sputum and serum as a novel biomarker of COPD
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Oxidative stress in expired breath condensate of patients with COPD: relationships with airway inflammation, and disease severity
Source: Eur Respir J 2002; 20: Suppl. 38, 284s
Year: 2002
Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept